The document discusses advancements in high-density self-assembling functional protein arrays for cancer research, focusing on serum screening and the detection of protein interactions and modifications. It highlights the advantages of next-generation cell-free protein microarrays, including cost-effectiveness, protein integrity, and customizability, as well as the launch of the Videssa® test for early breast cancer detection. The test utilizes biomarkers identified through these advanced arrays, demonstrating their practical application in reducing unnecessary breast biopsies.
Related topics: